Lonza Group
HR Business Partner Stein / Stücki
Early Derisking and Optimization
Potency Assessment
- Immunogenicity / Immunotoxicity Assessment
- Rapid Host Screen and Early Protein Expression
- Tailored License Application Program
API Support for Early Phase Development
Highly Potent API Technologies
Specialized Drug Product Development
- Micro-dosing for Early Human Clinical Studies
- Clinical Bottling, Labelling and Supply
- Design and Preformulation Development
Integrated Offerings
Specialized Modalities